Evidence map›Paper›PMID 29414631›Full record

SynthesisCancer epidemiology2018

Esophageal cancer male to female incidence ratios in Africa: A systematic review and meta-analysis of geographic, time and age trends.

Daniel R S Middleton, Liacine Bouaoun, Rachel Hanisch, Freddie Bray, Charles Dzamalala, Steady Chasimpha, Diana Menya, Charles Gombé Mbalawa, Guy N'Da, Mathewos A Woldegeorgis and 14 more

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Cancer epidemiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 13 institutions in 12 countries.

Daniel R S MiddletonSection of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France. Electronic address: middletond@fellows.iarc.fr.
Liacine BouaounSection of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.
Rachel HanischSection of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.
Freddie BraySection of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon, France.
Charles DzamalalaMalawi Cancer Registry, Queen Elizabeth Central Hospital, Blantyre, Malawi.
Steady ChasimphaMalawi Cancer Registry, Queen Elizabeth Central Hospital, Blantyre, Malawi.
Diana MenyaSchool of Public Health, Moi University, Eldoret, Kenya.
Charles Gombé MbalawaRegistre des Cancers de Brazzaville, Sce de Carcinologie et Radiothérapie, CHU de Brazzaville, Brazzaville, Congo.
Guy N'DaRegistre de Cancer d'Abidjan, Centre Hospitalier Universitaire de Treichville, Abidjan, Cote d'Ivoire.
Mathewos A WoldegeorgisAddis Ababa City Cancer Registry, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
Ramou NjieGNCR, The Gambia Hepatitis Intervention Study, International Agency for Research on Cancer, c/o MRC unit, Gambia.
Moussa KoulibalyRegistre de Cancer de Guinée, Université de Conakry, Conakry, Guinea.
Nathan BuzibaEldoret Cancer Registry, Moi University School of Medicine, Eldoret, Kenya.
Josefo FerroBeira Cancer Registry, Hospital Central da Beira, Beira, Mozambique.
Hassan NouhouRegistre des Cancers du Niger, Laboratoire d'Anatomie et Cytologie Pathologiques, Faculté des Sciences de la Santé, Niamey, Niger.
Femi OgunbiyiIbadan Cancer Registry, Department of Pathology, University College Hospital, Ibadan, Nigeria.
Henry R WabingaKampala Cancer Registry, Department of Pathology, College of Health Sciences, Makerere University, Kampala, Uganda.
Eric ChokunongaZimbabwe National Cancer Registry, Parirenyatwa Hospital, Harare, Zimbabwe.
Margaret Z BorokZimbabwe National Cancer Registry, Parirenyatwa Hospital, Harare, Zimbabwe.
Anne R KorirNairobi Cancer Registry, Kenya Medical Research Institute, Centre for Clinical Research, Nairobi, Kenya.
Amos O MwasamwajaKilimanjaro Christian Medial Centre, Moshi, Tanzania.
Blandina T MmbagaKilimanjaro Christian Medial Centre, Moshi, Tanzania.
Joachim SchüzSection of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.
Valerie A McCormackSection of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France.
Centre international de recherche sur le cancer · FRKilimanjaro Christian Medical Centre · TZMoi University · KEParirenyatwa Hospital · ZWQueen Elizabeth Central Hospital · MWAddis Ababa University · ETCentre Hospitalier et Universitaire de Brazzaville · CGGamal Abdel Nasser University of Conakry · GNKenya Medical Research Institute · KEMakerere University · UGMRC Unit the Gambia · GMUniversity College Hospital, Ibadan · NGUniversity Hospital Medical Center at Treichville · CI

Funding

Esophageal cancer in West KenyaR21CA191965 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI MCCORMACK, VALERIE · 2015 to 2016
$256k
Medical Research Council MC_UP_A900_1120NCI NIH HHS R21 CA191965World Health Organization 001
6 · The paper itself

Abstract

Esophageal squamous cell carcinoma (ESCC) remains the predominant histological subtype of esophageal cancer (EC) in many transitioning countries, with an enigmatic and geographically distinct etiology, and consistently elevated incidence rates in many Eastern and Southern African countries. To gain epidemiological insights into ESCC patterns across the continent, we conducted a systematic review and meta-analysis of male-to-female (M:F) sex ratios of EC age-standardised (world) incidence rates in Africa according to geography, time and age at diagnosis. Data from 197 populations in 36 countries were included in the analysis, based on data from cancer registries included in IARC's Cancer Incidence in Five Continents, Cancer in Africa and Cancer in Sub-Saharan Africa reports, alongside a systematic search of peer-reviewed literature. A consistent male excess in incidence rates overall (1.7; 95% CI: 1.4, 2.0), and in the high-risk Eastern (1.6; 95% CI: 1.4, 1.8) and Southern (1.8; 95% CI: 1.5, 2.0) African regions was observed. Within the latter two regions, there was a male excess evident in 30-39 year olds that was not observed in low-risk regions. Despite possible referral biases affecting the interpretability of the M:F ratios in place and time, the high degree of heterogeneity in ESCC incidence implies a large fraction of the disease is preventable, and directs research enquiries to elucidate early-age exposures among young men in Africa.

Indexed as

AdultAfricaAgedAge FactorsEsophageal NeoplasmsFemaleGeographyHumansIncidenceMaleMiddle AgedRegistriesTime FactorsYoung AdultAfricaEsophageal cancerMeta-analysisSex ratiosSystematic review

Identifiers

PMID29414631
PMCPMC5871654
OpenAlexW2794407478

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.